Promontory Therapeutics Gives Results on Cancer Treatment Candidate PT-112
By Karen E. Roman Promontory Therapeutics Inc., a clinical stage development company centered on...
By Karen E. Roman Promontory Therapeutics Inc., a clinical stage development company centered on...
By Karen E. Roman Olo Inc. (NYSE: OLO), an open SaaS which develops digital platforms...
By Tech Edge Editorial NetApp, Inc. (Nasdaq: NTAP) unveiled a range of products and...
By Tech Edge Editorial Veeam Software has unveiled significant updates to its data resiliency offerings...
By Tech Edge Editorial Qualcomm Inc. (Nasdaq: QCOM) unveiled new SoC offerings at the...
By Tech Edge Editorial Qualcomm Inc. (Nasdaq: QCOM) unveiled its latest premium mobile platform,...
By Daniella Parra FIGS, Inc. (NYSE: FIGS), a healthcare community lifestyle brand, reported net revenue...
By Exec Edge Editorial Staff Potbelly Corp. (Nasdaq: PBPB) said third quarter revenue increased...
By Thomas Green Portillo’s Inc. (Nasdaq: PTLO) said third quarter revenue rose 10.4% to $166.8...
By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Dr. James Bristol, an...